down arrow

Shivalik Rasayan

Part of MojoOne Strategy
  • Market Cap: Micro Cap
  • Industry: Chemicals
  • ISIN: INE788J01021
  • NSEID: SHIVALIK
  • BSEID: 539148
INR
597.00
14.35 (2.46%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 9.61 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

590.85598.10

52 Week

500.50873.60
Valuation
Technical
Day's Volume

CASH

9.61 k (-64.83%) Volume

Shareholding (Mar 2025)

FII

4.27%

Held by 15 FIIs

DII

0.64%

Held by 0 DIIs

Promoter

47.37%

iScoreScore
Part of MojoOne Strategy
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Company has a low Debt to Equity ratio (avg) at 0 times

 
2

Poor long term growth as Net Sales has grown by an annual rate of 10.97% and Operating profit at 3.77% over the last 5 years

 
3

With a growth in Net Profit of 59.91%, the company declared Very Positive results in Dec 24

4

Technical trend is Sideways signifying no clear price momentum

5

With ROCE of 4.4, it has a Fair valuation with a 1.7 Enterprise value to Capital Employed

6

Despite the size of the company, domestic mutual funds hold only 0% of the company

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Chemicals

stock-summary
Market cap

INR 929 Cr (Micro Cap)

stock-summary
P/E

56.00

stock-summary
Industry P/E

41

stock-summary
Dividend Yield

0.09%

stock-summary
Debt Equity

0.12

stock-summary
Return on Equity

2.77%

stock-summary
Price to Book

1.79

Revenue and Profits (1 Year):
Net Sales:
85 Cr
(Quarterly Results - Dec 2024)
Net Profit:
5 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.09%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
0.18%
0%
0.18%
1 Year
1.38%
0.08%
1.46%
2 Years
-22.52%
0.14%
-22.38%
3 Years
-38.75%
0.20%
-38.55%
4 Years
-15.45%
0.27%
-15.18%
5 Years
120.91%
0.98%
121.89%

Latest dividend: 0.5 per share ex-dividend date: Sep-20-2024

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
10.97%
EBIT Growth (5y)
3.77%
EBIT to Interest (avg)
10.51
Debt to EBITDA (avg)
1.18
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.68
Tax Ratio
11.83%
Dividend Payout Ratio
6.12%
Pledged Shares
0
Institutional Holding
4.91%
ROCE (avg)
10.85%
ROE (avg)
6.66%
Valuation key factors
Factor
Value
P/E Ratio
56
Industry P/E
41
Price to Book Value
1.79
EV to EBIT
34.96
EV to EBITDA
22.09
EV to Capital Employed
1.70
EV to Sales
3.08
PEG Ratio
1.82
Dividend Yield
0.09%
ROCE (Latest)
4.41%
ROE (Latest)
2.77%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bullish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 15 FIIs (4.27%)

Promoter with highest holding

Growel Remedies Limited (47.37%)

Highest Public shareholder

Ginnerup Capital Aps (3.22%)

Individual Investors Holdings

30.52%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 21.47% vs 22.44% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 72.22% vs -35.44% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "85.31",
          "val2": "70.23",
          "chgp": "21.47%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "13.32",
          "val2": "8.86",
          "chgp": "50.34%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.26",
          "val2": "1.58",
          "chgp": "43.04%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "5.27",
          "val2": "3.06",
          "chgp": "72.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "15.61%",
          "val2": "12.62%",
          "chgp": "2.99%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 19.44% vs 15.20% in Sep 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 24.26% vs -49.12% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "157.07",
          "val2": "131.51",
          "chgp": "19.44%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "21.14",
          "val2": "21.02",
          "chgp": "0.57%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "4.37",
          "val2": "3.44",
          "chgp": "27.03%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "7.53",
          "val2": "6.06",
          "chgp": "24.26%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "13.46%",
          "val2": "15.98%",
          "chgp": "-2.52%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 20.14% vs 17.62% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 40.35% vs -45.23% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "242.38",
          "val2": "201.74",
          "chgp": "20.14%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "34.46",
          "val2": "29.88",
          "chgp": "15.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "6.63",
          "val2": "5.02",
          "chgp": "32.07%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "12.80",
          "val2": "9.12",
          "chgp": "40.35%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "14.22%",
          "val2": "14.81%",
          "chgp": "-0.59%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 16.43% vs 9.17% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is -22.98% vs -17.06% in Mar 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "272.98",
          "val2": "234.45",
          "chgp": "16.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "39.18",
          "val2": "42.94",
          "chgp": "-8.76%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "7.63",
          "val2": "4.34",
          "chgp": "75.81%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "16.36",
          "val2": "21.24",
          "chgp": "-22.98%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "14.35%",
          "val2": "18.32%",
          "chgp": "-3.97%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - YoYstock-summary
Dec'24
Dec'23
Change(%)
Net Sales
85.31
70.23
21.47%
Operating Profit (PBDIT) excl Other Income
13.32
8.86
50.34%
Interest
2.26
1.58
43.04%
Exceptional Items
0.00
0.00
Consolidate Net Profit
5.27
3.06
72.22%
Operating Profit Margin (Excl OI)
15.61%
12.62%
2.99%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2024 is 21.47% vs 22.44% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Dec 2024 is 72.22% vs -35.44% in Dec 2023

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
157.07
131.51
19.44%
Operating Profit (PBDIT) excl Other Income
21.14
21.02
0.57%
Interest
4.37
3.44
27.03%
Exceptional Items
0.00
0.00
Consolidate Net Profit
7.53
6.06
24.26%
Operating Profit Margin (Excl OI)
13.46%
15.98%
-2.52%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 19.44% vs 15.20% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is 24.26% vs -49.12% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
242.38
201.74
20.14%
Operating Profit (PBDIT) excl Other Income
34.46
29.88
15.33%
Interest
6.63
5.02
32.07%
Exceptional Items
0.00
0.00
Consolidate Net Profit
12.80
9.12
40.35%
Operating Profit Margin (Excl OI)
14.22%
14.81%
-0.59%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 20.14% vs 17.62% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is 40.35% vs -45.23% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
272.98
234.45
16.43%
Operating Profit (PBDIT) excl Other Income
39.18
42.94
-8.76%
Interest
7.63
4.34
75.81%
Exceptional Items
0.00
0.00
Consolidate Net Profit
16.36
21.24
-22.98%
Operating Profit Margin (Excl OI)
14.35%
18.32%
-3.97%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 16.43% vs 9.17% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is -22.98% vs -17.06% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Shivalik Rasayan Ltd stock-summary
stock-summary
Shivalik Rasayan Ltd
Micro Cap
Chemicals
Shivalik Rasayan Limited was registered with the ROC, Gwalior, Madhya Pradesh dated 16 March 1979. The Company is manufacturer of Organophosphate Insecticides such as Dimethoate Technical and Malathion Technical. In year 2016, the Company acquired 44.12% equity shares of M/s Medicamen Biotech Limited in accordance with the Share Purchase Agreement with Promoters of M/s Medicamen Biotech Limited. The company took over the full management control in Medicamen Biotech Limited on 1st January 2016.
Company Coordinates stock-summary
Company Details
Village Kolhupani, P O Chandanwari Dehradun UTT : 248007
stock-summary
Tel: 91-0135-2772038/2773429
stock-summary
http://www.shivalikrasayan.in
stock-summary
srl@vsnl.com/srl@airtelmail.in
Registrar Details
Beetal Financial & Computer Services (P) Ltd , Beetal House , 99 Mandangir, 3rd Floor, Behind Local Shopping Centre, Near Dada Harsukhdas Mandir, New Delhi
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."